3. The Chemical Differences Between EPA and DHA

4. Lipid Effects of Drug Classes in Dyslipidemia and Hypertriglyceridemia

5. Icosapent Ethyl (Pure EPA) Median Placebo-Adjusted Change From Baseline for Efficacy End Points

6. Select Omega-3 Outcomes Studies

7. Anti Inflammatory Effects of Omega-3 Fatty Acids

8. Prescription-only Omega-3s vs Dietary Supplement Omega-3s

9. Mechanisms by Which EPA May Lower CVD

10. Incidence of Cancer Diagnosis With Omega-3 Fatty Acids

11. Effects of Omega-3 on Incident Heart Failure GISSI-Heart Failure Study

12. Omega-3 Ethyl Esters and Lipid Levels in Patients With Triglycerides > 500 mg/dL

13. Use of Omega 3 Fatty Acids In Clinical Practice

15. Safety of Omega-3 Fatty Acids

16. Reduction of Cardiovascular Events With EPA – Intervention Trial

17. Abbreviations

18. Abbreviations (cont)

19. Abbreviations (cont)

20. References

21. References (cont)

22. References (cont)

23. References (cont)